Publication not explained
Read the Original
This page is a summary of: N,N′-Alkane-diyl-bis-3-picoliniums as Nicotinic Receptor Antagonists: Inhibition of Nicotine-Evoked Dopamine Release and Hyperactivity, Journal of Pharmacology and Experimental Therapeutics, May 2008, American Society for Pharmacology & Experimental Therapeutics (ASPET), DOI: 10.1124/jpet.108.136630.
You can read the full text:
Be the first to contribute to this page